About us

ikona 11111

About us

Initially, the unit responsible to supporting clinical trials was the Clinical Trials Section (SBK), a subsection of the Innovation and Technology Transfer Centre (CIITT) of the Medical University of Łódź. In 2019 SBK was restructured into a separate entity, called Clinical Trials Centre (CBK). Two years later, the CBK was expanded into the highly specialized Clinical Trials Support Centre (CWBK), providing complex support in realization of commercial and noncommercial clinical trials. The aim of the project financed by the Medical Research Agency (ABM) was providing centralized architecture through the expansion of the unit from CBK into CWBK, the launch of the Early Phases Research Unit, providing effective systemic solutions and the human resources advancement modeled after the Medical Research Agency’s standards. The approximately 2.4 million euro projects realization begun in 2021, and ended with an official opening of the new facility on 29 of march 2022. The next expansion took place in march of 2025. The expansion project was called “Improving and increasing the scientific and research potential of the Clinical Research Support Centre at the Medical University of Łódź for provision of comprehensive clinical trials services – CWBK 2” (KPOD.07.07-IW.07-0319/24) and financed by the National Recovery and Resilience Plan (KPO). The project was financed with over 1.6 million euro, which empowers the unit in the capacity of further expansion and increasing its research capacity.

Currently we are working as a CRO/ARO and provide complex support with the planning, coordination and management of single and multi-OŚRODEK clinical trials, using advanced facilities and strong academic support We want to provide support wherever the administrative barriers collided with the swift realization of clinical trials. Our experience includes the complex management of projects during all of its steps – from the idea, through the realization until the final raport.

In the present day, we have managed to support Researchers, getting them cumulated funding of over 41 million euro. Currently, we are the leader of 9 project funded for approximately 38 million euro by the Medical Research Agency, and a KONSORCJANT in another 9, which have been cumulatively funded for over 3 million euro. We constantly analyze possible sources of funding, follow announced calls for proposals and applicable regulations.

Our mission consists of complex support in leading the highest quality clinical trials in the pursuit of knowledge and the search for answers to important questions concerning human health and the development of the most effective therapy technology. Our portfolio encompasses a wide array of disease areas such as Oncology, Hematology, Cardiology, Dermatology, Neurology, Metabolic diseases, Mental disorders, Rare diseases, Pediatrics or Rheumatology.